Cardiology
Conference Coverage
Promising first results with DNA editing to lower LDL
The first in-human HEART-1 trial of in vivo DNA editing called VERVE-101, shows reductions in LDL and PCSK9 protein in patients with familial...
News
Hourly air pollution exposure: A risk factor for stroke
“These variations in susceptibility highlight the importance of implementing effective health protection measures to reduce exposure to air...
Latest News
Albuminuria reduction fuels finerenone’s kidney benefits
Mediation analyses of finerenone trial data show most of the drug’s kidney benefit and a third of its CVD benefit comes from cutting albuminuria...
Latest News
Sleeping beats sitting? What a new study means for your patients
“Our study highlights that replacing sedentary behavior with any other behavior can be beneficial.”
Latest News
T2D: Real benefits of new oral antidiabetic drugs
What about in the real world? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective?
Conference Coverage
Pharmacist-based strategy places more patients on statins
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...
Conference Coverage
Low-salt diet cut BP by 6 mm Hg in 1 week: CARDIA-SSBP
“The blood pressure reduction we see here is ... comparable to that produced by one antihypertensive medication,” said Dr. Deepak Gupta.
Conference Coverage
Study takes fine-grained look at MACE risk with glucocorticoids in RA
The level of risk for MACE rose with the dose, duration, and recency of GC use, and risk increased significantly at prednisone-equivalent doses as...
Conference Coverage
Better postpartum BP control with self-monitoring: POP-HT
“This trial identifies a potential need for a paradigm shift in the way women affected by hypertensive pregnancy are managed postnatally,” said Dr...
Conference Coverage
Apixaban cuts stroke but ups bleeding in subclinical AFib: ARTESIA
The big question is whether the reduction in stroke with anticoagulation outweighs the increase in major bleeding.
Conference Coverage
Impressive bleeding profile with factor XI inhibitor in AFib: AZALEA
“This gives us real hope that we have finally found an anticoagulant that is remarkably safe,” said Dr. Christian Ruff.